Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome

Thesis (MMed) -- Stellenbosch University, 2022.

Saved in:
Bibliographic Details
Main Author: Duvenhage, Joanie
Other Authors: Schaaf, Hendrik Simon
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867614037978644480
access_status_str Open Access
author Duvenhage, Joanie
author2 Schaaf, Hendrik Simon
author_browse Duvenhage, Joanie
Schaaf, Hendrik Simon
author_facet Schaaf, Hendrik Simon
Duvenhage, Joanie
author_sort Duvenhage, Joanie
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (MMed) -- Stellenbosch University, 2022.
format Thesis
id oai:scholar.sun.ac.za:10019.1/126156
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:45:40.774Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/126156 Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome Duvenhage, Joanie Schaaf, Hendrik Simon Hesseling, Anneke Catharina Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Paediatrics and Child Health. Drugs -- Side effects Tuberculosis in children Drug resistance Hepatocellular Liver metastasis UCTD Thesis (MMed) -- Stellenbosch University, 2022. ENGLISH ABSTRACT: Background: Hepatocellular injury has been commonly reported in adults on treatment for rifampicin-resistant tuberculosis (RR-TB). However, there are limited data in children. Methods: Two observational pharmacokinetic studies of children (0-17 years) routinely treated for RR-TB were conducted in Cape Town, South Africa between October 2011 and February 2020. All hepatocellular injury adverse events (AEs; defined as elevated alanine aminotransferase [ALT]) were documented. Data were analyzed to determine the incidence, aetiology, risk factors, management and outcome of ALT elevation. Results: A total of 217 children, median age 3.6 years at enrolment (IQR: 1.7, 7.1) were included. The median follow-up time was 14.0 months (IQR: 9.8, 17.2). Fifty-five (25.3%) developed an ALT AE. Of these, 43/55 (78%) children had 54 ALT AEs attributed to their RR-TB treatment. The incidence rate of ALT AEs related to RR-TB treatment was 22.4 per 100 person-years. Positive HIV status and having an elevated ALT at enrolment were associated with time to ALT AE attributed to RR-TB treatment, with p-values of 0.0427 and p<0.0001, respectively. Hepatitis A IgM was positive in 11/14 (78.6%) of grade ≥3 cases of ALT AEs. In 8/14 (57%) of severe ALT AEs, hepatotoxic drugs were stopped or temporarily interrupted. No children had a fatal or unresolved outcome. Conclusions: Hepatocellular injury in children on RR-TB treatment is common, although usually mild; having elevated ALT early in treatment and HIV-positive status are possible risk factors for the development of hepatocellular injury on treatment. Hepatitis A was a common cause of severe ALT AE in children treated for RR-TB. AFRIKAANSE OPSOMMING: Geen opsomming beskikbaar. Masters 2022-11-17T11:02:00Z 2023-01-16T12:52:57Z 2022-11-17T11:02:00Z 2023-01-16T12:52:57Z 2021-08 Thesis http://hdl.handle.net/10019.1/126156 en_ZA Stellenbosch University 117 pages application/pdf Stellenbosch : Stellenbosch University
spellingShingle Drugs -- Side effects
Tuberculosis in children
Drug resistance
Hepatocellular
Liver metastasis
UCTD
Duvenhage, Joanie
Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome
title Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome
title_full Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome
title_fullStr Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome
title_full_unstemmed Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome
title_short Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome
title_sort hepatocellular injury in children treated for rifampicin resistant tuberculosis incidence aetiology and outcome
topic Drugs -- Side effects
Tuberculosis in children
Drug resistance
Hepatocellular
Liver metastasis
UCTD
url http://hdl.handle.net/10019.1/126156
work_keys_str_mv AT duvenhagejoanie hepatocellularinjuryinchildrentreatedforrifampicinresistanttuberculosisincidenceaetiologyandoutcome